{"id":18065,"date":"2015-03-02T17:16:22","date_gmt":"2015-03-02T17:16:22","guid":{"rendered":"https:\/\/www.clpu.es\/rss_externo\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\/"},"modified":"2015-03-02T17:16:22","modified_gmt":"2015-03-02T17:16:22","slug":"basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients","status":"publish","type":"rss_externo","link":"https:\/\/www.clpu.es\/en\/rss_externo\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\/","title":{"rendered":"Basal cell carcinoma drug encourages both cancer regression and loss of taste in patients"},"content":{"rendered":"<p>Many patients undergoing chemotherapy experience severe taste disruptions that make eating a challenge at a time when maintaining good nutrition is extremely important. Now, researchers report that they have identified the pathway responsible for taste changes among users of chemotherapy drugs that treat basal cell carcinoma.<br \/><a href='http:\/\/feeds.sciencedaily.com\/~r\/sciencedaily\/~3\/QwrzjrKoNYE\/150302121622.htm' title='Basal cell carcinoma drug encourages both cancer regression and loss of taste in patients' target='_blank' rel=\"noopener\">http:\/\/feeds.sciencedaily.com\/~r\/sciencedaily\/~3\/QwrzjrKoNYE\/150302121622.htm<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false},"class_list":["post-18065","rss_externo","type-rss_externo","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Basal cell carcinoma drug encourages both cancer regression and loss of taste in patients - CLPU<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.clpu.es\/rss_externo\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Basal cell carcinoma drug encourages both cancer regression and loss of taste in patients - CLPU\" \/>\n<meta property=\"og:description\" content=\"Many patients undergoing chemotherapy experience severe taste disruptions that make eating a challenge at a time when maintaining good nutrition is extremely important. Now, researchers report that they have identified the pathway responsible for taste changes among users of chemotherapy drugs that treat basal cell carcinoma.http:\/\/feeds.sciencedaily.com\/~r\/sciencedaily\/~3\/QwrzjrKoNYE\/150302121622.htm\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.clpu.es\/rss_externo\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\/\" \/>\n<meta property=\"og:site_name\" content=\"CLPU\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.clpu.es\\\/rss_externo\\\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\\\/\",\"url\":\"https:\\\/\\\/www.clpu.es\\\/rss_externo\\\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\\\/\",\"name\":\"Basal cell carcinoma drug encourages both cancer regression and loss of taste in patients - CLPU\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.clpu.es\\\/#website\"},\"datePublished\":\"2015-03-02T17:16:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.clpu.es\\\/rss_externo\\\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.clpu.es\\\/rss_externo\\\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.clpu.es\\\/rss_externo\\\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/www.clpu.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RSS externos\",\"item\":\"https:\\\/\\\/www.clpu.es\\\/rss_externo\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Basal cell carcinoma drug encourages both cancer regression and loss of taste in patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.clpu.es\\\/#website\",\"url\":\"https:\\\/\\\/www.clpu.es\\\/\",\"name\":\"CLPU\",\"description\":\"Centro de L\u00e1seres Pulsados\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.clpu.es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Basal cell carcinoma drug encourages both cancer regression and loss of taste in patients - CLPU","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.clpu.es\/rss_externo\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\/","og_locale":"en_US","og_type":"article","og_title":"Basal cell carcinoma drug encourages both cancer regression and loss of taste in patients - CLPU","og_description":"Many patients undergoing chemotherapy experience severe taste disruptions that make eating a challenge at a time when maintaining good nutrition is extremely important. Now, researchers report that they have identified the pathway responsible for taste changes among users of chemotherapy drugs that treat basal cell carcinoma.http:\/\/feeds.sciencedaily.com\/~r\/sciencedaily\/~3\/QwrzjrKoNYE\/150302121622.htm","og_url":"https:\/\/www.clpu.es\/rss_externo\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\/","og_site_name":"CLPU","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.clpu.es\/rss_externo\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\/","url":"https:\/\/www.clpu.es\/rss_externo\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\/","name":"Basal cell carcinoma drug encourages both cancer regression and loss of taste in patients - CLPU","isPartOf":{"@id":"https:\/\/www.clpu.es\/#website"},"datePublished":"2015-03-02T17:16:22+00:00","breadcrumb":{"@id":"https:\/\/www.clpu.es\/rss_externo\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.clpu.es\/rss_externo\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.clpu.es\/rss_externo\/basal-cell-carcinoma-drug-encourages-both-cancer-regression-and-loss-of-taste-in-patients\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/www.clpu.es\/en\/"},{"@type":"ListItem","position":2,"name":"RSS externos","item":"https:\/\/www.clpu.es\/rss_externo\/"},{"@type":"ListItem","position":3,"name":"Basal cell carcinoma drug encourages both cancer regression and loss of taste in patients"}]},{"@type":"WebSite","@id":"https:\/\/www.clpu.es\/#website","url":"https:\/\/www.clpu.es\/","name":"CLPU","description":"Centro de L\u00e1seres Pulsados","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.clpu.es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.clpu.es\/en\/wp-json\/wp\/v2\/rss_externo\/18065","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.clpu.es\/en\/wp-json\/wp\/v2\/rss_externo"}],"about":[{"href":"https:\/\/www.clpu.es\/en\/wp-json\/wp\/v2\/types\/rss_externo"}],"author":[{"embeddable":true,"href":"https:\/\/www.clpu.es\/en\/wp-json\/wp\/v2\/users\/2"}],"wp:attachment":[{"href":"https:\/\/www.clpu.es\/en\/wp-json\/wp\/v2\/media?parent=18065"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}